Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant gap (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant gap (Expand Search)
-
2641
-
2642
-
2643
Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression.
Published 2025Subjects: -
2644
Myocardial <i>Shroom3</i> loss during development does not show abnormal semilunar valves.
Published 2025Subjects: -
2645
-
2646
-
2647
-
2648
Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects.
Published 2025Subjects: -
2649
-
2650
-
2651
Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness.
Published 2025Subjects: -
2652
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show ventricular septal defects.
Published 2025Subjects: -
2653
<i>Shroom3</i> is expressed throughout the mouse myocardium during cardiogenesis.
Published 2025Subjects: -
2654
-
2655
-
2656
-
2657
-
2658
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show left ventricular thinning.
Published 2025Subjects: -
2659
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show abnormal semilunar valves.
Published 2025Subjects: -
2660